N@N

BioScrip, Inc. to Present at ThinkEquitya?s Mid Year Check-Up on Healthcare Conference

_{//health-fitness.news-articles.net/content/2010/ .. -mid-year-check-up-on-healthcare-conference.html}
^{Published in Health and Fitness on Thursday, June 10th 2010 at 14:50 GMT by Market Wire}  

ELMSFORD, N.Y.--([ BUSINESS WIRE ])--BioScrip, Inc. (Nasdaq: BIOS) today announced that the Company will present at ThinkEquitya™s Mid Year Check-Up on Healthcare Conference on June 16, 2010 to be held at the Princeton Club in New York City.

Richard H. Friedman, Chairman and Chief Executive Officer, and Richard M. Smith, President and Chief Operating Officer, will present at 1:30 PM EDT. A live audio webcast of the event may be accessed at [ http://www.wsw.com/webcast/tep18/bios/ ].

A replay of each presentation will be available through BioScripa™s website at [ www.bioscrip.com ] under the aInvestor Relationsa section and will remain available through Wednesday, June 30, 2010.

About BioScrip, Inc.

BioScrip, Inc. ([ www.bioscrip.com ]) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payers and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.